Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Nutritional, Gastrointestinal and Endo-Metabolic Traps in the Management of Children with Spinal Muscular Atrophy Type 1

Antonio Corsello
,
Lorenzo Scatigno
,
Martina Chiara Pascuzzi
,
Valeria Calcaterra
ORCID logo ,
Dario Dilillo
,
Sara Vizzuso
ORCID logo ,
Gloria Pelizzo
,
Elena Zoia
,
Anna Mandelli
,
Annalisa Govoni
,
Alessandra Bosetti
,
Ruggiero Francavilla
* ORCID logo ,
Flavia Indrio
* ,
Valentina Fabiano
ORCID logo ,
Gianvincenzo Zuccotti
ORCID logo ,
Elvira Verduci
ORCID logo
Version 1 : Received: 4 June 2021 / Approved: 7 June 2021 / Online: 7 June 2021 (13:14:37 CEST)

A peer-reviewed article of this Preprint also exists.

Corsello, A.; Scatigno, L.; Pascuzzi, M.C.; Calcaterra, V.; Dilillo, D.; Vizzuso, S.; Pelizzo, G.; Zoia, E.; Mandelli, A.; Govoni, A.; Bosetti, A.; Francavilla, R.; Indrio, F.; Fabiano, V.; Zuccotti, G.V.; Verduci, E. Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1. Nutrients 2021, 13, 2400. Corsello, A.; Scatigno, L.; Pascuzzi, M.C.; Calcaterra, V.; Dilillo, D.; Vizzuso, S.; Pelizzo, G.; Zoia, E.; Mandelli, A.; Govoni, A.; Bosetti, A.; Francavilla, R.; Indrio, F.; Fabiano, V.; Zuccotti, G.V.; Verduci, E. Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1. Nutrients 2021, 13, 2400.

Abstract

The management of patients with spinal muscular atrophy type 1 (SMA1) is constantly evolving. In just a few decades the medical approach has switched from an exclusively palliative therapy to a targeted therapy, transforming the natural history of the disease, improving survival time and quality of life, and creating new challenges and goals. Many nutritional problems, gastrointesti-nal disorders and metabolic and endocrine alterations are commonly identified in patients af-fected by SMA1 during childhood and adolescence. For this reason, a proper pediatric multidis-ciplinary approach is then required in the clinical care of these patients, with a specific focus on the prevention of most common complications. The purpose of this narrative review is to provide the clinician with a practical and usable tool about SMA1 patients care, through a comprehensive insight into the nutritional, gastroenterological, metabolic and endocrine management of SMA1. Considering the possible horizons opened thanks to new therapeutic frontiers, a nutritional and endo-metabolic surveillance is a crucial element to be considered for a proper clinical care of these patients.

Keywords

SMA; spinal muscular atrophy type 1; SMN1; nutritional management; enteral nutrition; pediatric gastroenterology; dysphagia; neurological disability; endocrine disorders; precocious pubarche

Subject

Medicine and Pharmacology, Pediatrics, Perinatology and Child Health

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.